PhRMA warned that the US risks losing ground to China in the biomedical innovation race if government policies like Medicare price negotiation are not changed. (Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
